News

P21 for GLP-1 Cognitive Fog: VA Trial Lessons

GLP-1 agonists can cause cognitive fog, but a 2023 VA trial on P21 for alcohol-related impairment offers clues. This peptide improved executive function

P21 and GLP-1 Alcohol Trials: Cognitive Fog in ...

Veterans in GLP-1 alcohol trials sometimes face cognitive fog that hinders participation. This article explores P21, a synthetic peptide, as a potential

P21 and Pinealon Synergy for Age-Related Cognit...

P21 and Pinealon, two peptides under FDA review as a nootropic stack, target age-related cognitive decline through neurogenesis and epigenetic

Selank for Performance Anxiety Under FDA Scrutiny

Selank, a synthetic tuftsin analogue, shows promise for anxiety without sedation, but FDA scrutiny and a lack of performance-specific trials leave its future

P21 for Chemobrain: Can This Peptide Reverse Ch...

Chemobrain affects up to 50% of cancer survivors, yet no approved treatment exists. The peptide P21 shows promise in animal studies by boosting

P21 vs. Cerebrolysin for Post-Concussion Cognit...

Comparing P21 and Cerebrolysin for post-concussion cognitive recovery: a walk through the preclinical and clinical evidence, mechanisms, safety, and